The feasibility of robot-assisted laparoscopic radical cystectomy with pelvic lymphadenectomy: From the viewpoint of extended pelvic lymphadenectomy

Chul Kang Seung, Sung-Gu Kang, Hoon Choi, Hwii Ko Young, Jeong Gu Lee, Je-Jong Kim, Seok Ho Kang, Jun Cheon

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Purpose: We evaluated the feasibility of robot-assisted laparoscopic radical cystectomy (RARC) with pelvic lymph node dissection (PLND), especially extended PLND (ePLND), during our initial experience with this technique. Materials and Methods: From August 2007 to March 2009, prospective data were obtained from the 21 consecutive patients who underwent RARC with PLND at Korea University Hospital. Data included baseline characteristics, perioperative variables, pathological outcomes, and complications. Evidence of the lymph node yield curve was examined by using linear regression to compare the number of lymph nodes obtained. Results: Among 21 patients who underwent RARC, 13 had ileal conduit urinary diversion and 8 had orthotopic neobladder. Standard PLND (sPLND) was performed in the first 15 patients, and ePLND was performed in the more recent 6 patients. The mean total operative time was 515.5±145.1 minutes, and the mean estimated blood loss was 346.8±205.9 ml. The mean time for PLND was 106.7±25.2 minutes in patients with ePLND and 72.1±14.1 minutes in patients with sPLND (p=0.001). All patients had negative surgical margins. The mean number of retrieved nodes was 23.5±12.8 (range, 8-50) in all patients: 38.6±10.8 (range, 29-50) in ePLND and 15.7±12.2 (range, 8-21) in sPLND. Conclusions: Perioperative data and oncologic features showed that RARC with PLND is feasible. Robot-assisted laparoscopic surgery is a safe and effective procedure with acceptable morbidity and good oncologic results from the viewpoint of PLND, especially ePLND.

Original languageEnglish
Pages (from-to)870-878
Number of pages9
JournalKorean Journal of Urology
Volume50
Issue number9
DOIs
Publication statusPublished - 2009 Sep 1

Fingerprint

Cystectomy
Lymph Node Excision
Urinary Diversion
Lymph Nodes
Korea
Operative Time
Laparoscopy
Linear Models
Morbidity

Keywords

  • Cystectomy
  • Laparoscopy
  • Lymphadenectomy
  • Robotics
  • Urinary bladder neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

@article{1d7c04fe3ff643958498458bb234f2fa,
title = "The feasibility of robot-assisted laparoscopic radical cystectomy with pelvic lymphadenectomy: From the viewpoint of extended pelvic lymphadenectomy",
abstract = "Purpose: We evaluated the feasibility of robot-assisted laparoscopic radical cystectomy (RARC) with pelvic lymph node dissection (PLND), especially extended PLND (ePLND), during our initial experience with this technique. Materials and Methods: From August 2007 to March 2009, prospective data were obtained from the 21 consecutive patients who underwent RARC with PLND at Korea University Hospital. Data included baseline characteristics, perioperative variables, pathological outcomes, and complications. Evidence of the lymph node yield curve was examined by using linear regression to compare the number of lymph nodes obtained. Results: Among 21 patients who underwent RARC, 13 had ileal conduit urinary diversion and 8 had orthotopic neobladder. Standard PLND (sPLND) was performed in the first 15 patients, and ePLND was performed in the more recent 6 patients. The mean total operative time was 515.5±145.1 minutes, and the mean estimated blood loss was 346.8±205.9 ml. The mean time for PLND was 106.7±25.2 minutes in patients with ePLND and 72.1±14.1 minutes in patients with sPLND (p=0.001). All patients had negative surgical margins. The mean number of retrieved nodes was 23.5±12.8 (range, 8-50) in all patients: 38.6±10.8 (range, 29-50) in ePLND and 15.7±12.2 (range, 8-21) in sPLND. Conclusions: Perioperative data and oncologic features showed that RARC with PLND is feasible. Robot-assisted laparoscopic surgery is a safe and effective procedure with acceptable morbidity and good oncologic results from the viewpoint of PLND, especially ePLND.",
keywords = "Cystectomy, Laparoscopy, Lymphadenectomy, Robotics, Urinary bladder neoplasms",
author = "Seung, {Chul Kang} and Sung-Gu Kang and Hoon Choi and Young, {Hwii Ko} and Lee, {Jeong Gu} and Je-Jong Kim and Kang, {Seok Ho} and Jun Cheon",
year = "2009",
month = "9",
day = "1",
doi = "10.4111/kju.2009.50.9.870",
language = "English",
volume = "50",
pages = "870--878",
journal = "Korean Journal of Urology",
issn = "2005-6737",
publisher = "Korean Urological Association",
number = "9",

}

TY - JOUR

T1 - The feasibility of robot-assisted laparoscopic radical cystectomy with pelvic lymphadenectomy

T2 - From the viewpoint of extended pelvic lymphadenectomy

AU - Seung, Chul Kang

AU - Kang, Sung-Gu

AU - Choi, Hoon

AU - Young, Hwii Ko

AU - Lee, Jeong Gu

AU - Kim, Je-Jong

AU - Kang, Seok Ho

AU - Cheon, Jun

PY - 2009/9/1

Y1 - 2009/9/1

N2 - Purpose: We evaluated the feasibility of robot-assisted laparoscopic radical cystectomy (RARC) with pelvic lymph node dissection (PLND), especially extended PLND (ePLND), during our initial experience with this technique. Materials and Methods: From August 2007 to March 2009, prospective data were obtained from the 21 consecutive patients who underwent RARC with PLND at Korea University Hospital. Data included baseline characteristics, perioperative variables, pathological outcomes, and complications. Evidence of the lymph node yield curve was examined by using linear regression to compare the number of lymph nodes obtained. Results: Among 21 patients who underwent RARC, 13 had ileal conduit urinary diversion and 8 had orthotopic neobladder. Standard PLND (sPLND) was performed in the first 15 patients, and ePLND was performed in the more recent 6 patients. The mean total operative time was 515.5±145.1 minutes, and the mean estimated blood loss was 346.8±205.9 ml. The mean time for PLND was 106.7±25.2 minutes in patients with ePLND and 72.1±14.1 minutes in patients with sPLND (p=0.001). All patients had negative surgical margins. The mean number of retrieved nodes was 23.5±12.8 (range, 8-50) in all patients: 38.6±10.8 (range, 29-50) in ePLND and 15.7±12.2 (range, 8-21) in sPLND. Conclusions: Perioperative data and oncologic features showed that RARC with PLND is feasible. Robot-assisted laparoscopic surgery is a safe and effective procedure with acceptable morbidity and good oncologic results from the viewpoint of PLND, especially ePLND.

AB - Purpose: We evaluated the feasibility of robot-assisted laparoscopic radical cystectomy (RARC) with pelvic lymph node dissection (PLND), especially extended PLND (ePLND), during our initial experience with this technique. Materials and Methods: From August 2007 to March 2009, prospective data were obtained from the 21 consecutive patients who underwent RARC with PLND at Korea University Hospital. Data included baseline characteristics, perioperative variables, pathological outcomes, and complications. Evidence of the lymph node yield curve was examined by using linear regression to compare the number of lymph nodes obtained. Results: Among 21 patients who underwent RARC, 13 had ileal conduit urinary diversion and 8 had orthotopic neobladder. Standard PLND (sPLND) was performed in the first 15 patients, and ePLND was performed in the more recent 6 patients. The mean total operative time was 515.5±145.1 minutes, and the mean estimated blood loss was 346.8±205.9 ml. The mean time for PLND was 106.7±25.2 minutes in patients with ePLND and 72.1±14.1 minutes in patients with sPLND (p=0.001). All patients had negative surgical margins. The mean number of retrieved nodes was 23.5±12.8 (range, 8-50) in all patients: 38.6±10.8 (range, 29-50) in ePLND and 15.7±12.2 (range, 8-21) in sPLND. Conclusions: Perioperative data and oncologic features showed that RARC with PLND is feasible. Robot-assisted laparoscopic surgery is a safe and effective procedure with acceptable morbidity and good oncologic results from the viewpoint of PLND, especially ePLND.

KW - Cystectomy

KW - Laparoscopy

KW - Lymphadenectomy

KW - Robotics

KW - Urinary bladder neoplasms

UR - http://www.scopus.com/inward/record.url?scp=70349282266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349282266&partnerID=8YFLogxK

U2 - 10.4111/kju.2009.50.9.870

DO - 10.4111/kju.2009.50.9.870

M3 - Article

AN - SCOPUS:70349282266

VL - 50

SP - 870

EP - 878

JO - Korean Journal of Urology

JF - Korean Journal of Urology

SN - 2005-6737

IS - 9

ER -